196 related articles for article (PubMed ID: 19662370)
1. Effects of 5-Aza-CdR on the proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene.
Xiong H; Qiu H; Zhuang L; Xiong H; Jiang R; Chen Y
J Huazhong Univ Sci Technolog Med Sci; 2009 Aug; 29(4):498-502. PubMed ID: 19662370
[TBL] [Abstract][Full Text] [Related]
2. Effects of 5-Aza-CdR on cell proliferation of breast cancer cell line MDA-MB-435S and expression of maspin gene.
Zhang B; Huang T; Liu K; Chen J; Wang G
J Huazhong Univ Sci Technolog Med Sci; 2007 Oct; 27(5):543-6. PubMed ID: 18060631
[TBL] [Abstract][Full Text] [Related]
3. [Effect of 5-aza-2'-deoxycytidine on cell of high-risk patients with myelodysplastic syndrome in vitro].
Tong HY; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):467-71. PubMed ID: 15363133
[TBL] [Abstract][Full Text] [Related]
4. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.
Mirza S; Sharma G; Pandya P; Ralhan R
Mol Cell Biochem; 2010 Sep; 342(1-2):101-9. PubMed ID: 20455010
[TBL] [Abstract][Full Text] [Related]
5. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells.
Yang J; Tian X; Yang J; Cui J; Jiang S; Shi R; Liu Y; Liu X; Xu W; Xie W; Jia X; Bade R; Zhang T; Zhang M; Gong K; Yan S; Yang Z; Shao G
J Toxicol Environ Health A; 2017; 80(22):1222-1229. PubMed ID: 28880816
[TBL] [Abstract][Full Text] [Related]
6. ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.
Fan J; Yin WJ; Lu JS; Wang L; Wu J; Wu FY; Di GH; Shen ZZ; Shao ZM
J Cancer Res Clin Oncol; 2008 Aug; 134(8):883-90. PubMed ID: 18264725
[TBL] [Abstract][Full Text] [Related]
7. [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].
Tang B; Peng ZH; Jiang J
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1545-9. PubMed ID: 16412295
[TBL] [Abstract][Full Text] [Related]
8. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
[TBL] [Abstract][Full Text] [Related]
9. 5-Aza-2'-deoxycytidine may influence the proliferation and apoptosis of cervical cancer cells via demethylation in a dose- and time-dependent manner.
Yao TT; Mo SM; Liu LY; Lu HW; Huang ML; Lin ZQ
Genet Mol Res; 2013 Feb; 12(1):312-8. PubMed ID: 23408418
[TBL] [Abstract][Full Text] [Related]
10. Effect of 5-aza-2'-deoxycytidine on cell proliferation of non- small cell lung cancer cell line A549 cells and expression of the TFPI-2 gene.
Dong YQ; Liang JS; Zhu SB; Zhang XM; Ji T; Xu JH; Yin GL
Asian Pac J Cancer Prev; 2013; 14(7):4421-6. PubMed ID: 23992014
[TBL] [Abstract][Full Text] [Related]
11. [Effect of a methylation inhibitor 5-aza-2'-deoxycytidine on SHP-1 gene expression, proliferation and apoptosis in K562 cells].
Luo JM; Li Y; Yang L; Liu XJ; Wen SP; Wang FX; Zhang JY; Zhang XJ; Dong ZR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):309-14. PubMed ID: 19379557
[TBL] [Abstract][Full Text] [Related]
12. 5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.
Zhang H; Qi F; Cao Y; Zu X; Chen M; Li Z; Qi L
Cancer Biother Radiopharm; 2013 May; 28(4):343-50. PubMed ID: 23570371
[TBL] [Abstract][Full Text] [Related]
13. [SHP-1 gene's methylation status of Daudi lymphoma cell and the demethylation effect of 5-aza-2'-deoxycytidine].
Fang JC; Su ZL; Qiu G; He D; Feng ZY; Zhu MF; Li L; He XL
Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):670-4. PubMed ID: 17343198
[TBL] [Abstract][Full Text] [Related]
14. [Effect of 5-aza-2'-deoxycytidine on growth and methylation of RUNX3 gene in human pancreatic cancer cell line MiaPaca2].
Han X; Tan ZJ; Guo RD; Li ZJ; Wang YL
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):17-21. PubMed ID: 23648294
[TBL] [Abstract][Full Text] [Related]
15. Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.
Christoph F; Kempkensteffen C; Weikert S; Köllermann J; Krause H; Miller K; Schostak M; Schrader M
Br J Cancer; 2006 Dec; 95(12):1701-7. PubMed ID: 17133271
[TBL] [Abstract][Full Text] [Related]
16. HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.
Chai G; Li L; Zhou W; Wu L; Zhao Y; Wang D; Lu S; Yu Y; Wang H; McNutt MA; Hu YG; Chen Y; Yang Y; Wu X; Otterson GA; Zhu WG
PLoS One; 2008 Jun; 3(6):e2445. PubMed ID: 18560576
[TBL] [Abstract][Full Text] [Related]
17. [Apoptosis and re-expression of p16 gene in the myeloma cell line U266 induced by synergy of histone deacetylase inhibitor and demethylating agent].
Du HL; Qi Y; Shi YJ; Bu DF; Wu SL
Ai Zheng; 2002 Oct; 21(10):1057-61. PubMed ID: 12508642
[TBL] [Abstract][Full Text] [Related]
18. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms.
Schneider-Stock R; Diab-Assef M; Rohrbeck A; Foltzer-Jourdainne C; Boltze C; Hartig R; Schönfeld P; Roessner A; Gali-Muhtasib H
J Pharmacol Exp Ther; 2005 Feb; 312(2):525-36. PubMed ID: 15547111
[TBL] [Abstract][Full Text] [Related]
19. S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth.
Chuang JC; Warner SL; Vollmer D; Vankayalapati H; Redkar S; Bearss DJ; Qiu X; Yoo CB; Jones PA
Mol Cancer Ther; 2010 May; 9(5):1443-50. PubMed ID: 20442312
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.
Hassler MR; Klisaroska A; Kollmann K; Steiner I; Bilban M; Schiefer AI; Sexl V; Egger G
Biochimie; 2012 Nov; 94(11):2297-307. PubMed ID: 22687603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]